Benzimidazole derivative and preparation method and application as medicine thereof

The invention relates to a novel benzimidazole PPAR alpha/gamma/delta panto-agonist as shown in the general formula (I) and a preparation method thereof and application of a medicine compound containing the derivative in preparing a medicine for preventing or/and treating abnormal glucose metabolism...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LI ZHENG, LIU ROUJIA, ZHANG LUYONG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LI ZHENG
LIU ROUJIA
ZHANG LUYONG
description The invention relates to a novel benzimidazole PPAR alpha/gamma/delta panto-agonist as shown in the general formula (I) and a preparation method thereof and application of a medicine compound containing the derivative in preparing a medicine for preventing or/and treating abnormal glucose metabolism or/and abnormal lipids metabolism disease. The PPAR alpha/gamma/delta panto-agonist has excellent in-vivo hypoglycemic activity and blood fat adjusting action, can be applied for preparing medicines for preventing or/and treating metabolic syndrome related diseases of diabetes, obesity, hyperlipidemia, atherosclerosis, fatty liver and the like, and has wide application prospects. 本发明涉及类通式(I)所示的新型苯并咪唑类PPARα/γ/δ泛激动剂、其制备方法及含有该衍生物的药物组合物作为制备预防或/和治疗葡萄糖代谢异常或/和脂质代谢异常疾病的药物用途。所述的PPARα/γ/δ泛激动剂具有优异的体内降血糖活性及调节血脂作用,可应用于制备预防或/和治疗糖尿病、肥胖症、高血脂、动脉粥样硬化及脂肪肝等代谢综合症相关疾病的药物,具有广阔的应用前景。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN109456274A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN109456274A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN109456274A3</originalsourceid><addsrcrecordid>eNrjZAh2Ss2ryszNTEmsys9JVUhJLcosSyzJLEtVSMxLUSgoSi1ILALy8_MUclNLMvJTwMKJBQU5mckQ4cRioExKZnJmXqpCSUZqUWp-Gg8Da1piTnEqL5TmZlB0cw1x9tBNLciPTy0uSExOzUstiXf2MzSwNDE1MzI3cTQmRg0Aq-85BQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Benzimidazole derivative and preparation method and application as medicine thereof</title><source>esp@cenet</source><creator>LI ZHENG ; LIU ROUJIA ; ZHANG LUYONG</creator><creatorcontrib>LI ZHENG ; LIU ROUJIA ; ZHANG LUYONG</creatorcontrib><description>The invention relates to a novel benzimidazole PPAR alpha/gamma/delta panto-agonist as shown in the general formula (I) and a preparation method thereof and application of a medicine compound containing the derivative in preparing a medicine for preventing or/and treating abnormal glucose metabolism or/and abnormal lipids metabolism disease. The PPAR alpha/gamma/delta panto-agonist has excellent in-vivo hypoglycemic activity and blood fat adjusting action, can be applied for preparing medicines for preventing or/and treating metabolic syndrome related diseases of diabetes, obesity, hyperlipidemia, atherosclerosis, fatty liver and the like, and has wide application prospects. 本发明涉及类通式(I)所示的新型苯并咪唑类PPARα/γ/δ泛激动剂、其制备方法及含有该衍生物的药物组合物作为制备预防或/和治疗葡萄糖代谢异常或/和脂质代谢异常疾病的药物用途。所述的PPARα/γ/δ泛激动剂具有优异的体内降血糖活性及调节血脂作用,可应用于制备预防或/和治疗糖尿病、肥胖症、高血脂、动脉粥样硬化及脂肪肝等代谢综合症相关疾病的药物,具有广阔的应用前景。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190312&amp;DB=EPODOC&amp;CC=CN&amp;NR=109456274A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190312&amp;DB=EPODOC&amp;CC=CN&amp;NR=109456274A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI ZHENG</creatorcontrib><creatorcontrib>LIU ROUJIA</creatorcontrib><creatorcontrib>ZHANG LUYONG</creatorcontrib><title>Benzimidazole derivative and preparation method and application as medicine thereof</title><description>The invention relates to a novel benzimidazole PPAR alpha/gamma/delta panto-agonist as shown in the general formula (I) and a preparation method thereof and application of a medicine compound containing the derivative in preparing a medicine for preventing or/and treating abnormal glucose metabolism or/and abnormal lipids metabolism disease. The PPAR alpha/gamma/delta panto-agonist has excellent in-vivo hypoglycemic activity and blood fat adjusting action, can be applied for preparing medicines for preventing or/and treating metabolic syndrome related diseases of diabetes, obesity, hyperlipidemia, atherosclerosis, fatty liver and the like, and has wide application prospects. 本发明涉及类通式(I)所示的新型苯并咪唑类PPARα/γ/δ泛激动剂、其制备方法及含有该衍生物的药物组合物作为制备预防或/和治疗葡萄糖代谢异常或/和脂质代谢异常疾病的药物用途。所述的PPARα/γ/δ泛激动剂具有优异的体内降血糖活性及调节血脂作用,可应用于制备预防或/和治疗糖尿病、肥胖症、高血脂、动脉粥样硬化及脂肪肝等代谢综合症相关疾病的药物,具有广阔的应用前景。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAh2Ss2ryszNTEmsys9JVUhJLcosSyzJLEtVSMxLUSgoSi1ILALy8_MUclNLMvJTwMKJBQU5mckQ4cRioExKZnJmXqpCSUZqUWp-Gg8Da1piTnEqL5TmZlB0cw1x9tBNLciPTy0uSExOzUstiXf2MzSwNDE1MzI3cTQmRg0Aq-85BQ</recordid><startdate>20190312</startdate><enddate>20190312</enddate><creator>LI ZHENG</creator><creator>LIU ROUJIA</creator><creator>ZHANG LUYONG</creator><scope>EVB</scope></search><sort><creationdate>20190312</creationdate><title>Benzimidazole derivative and preparation method and application as medicine thereof</title><author>LI ZHENG ; LIU ROUJIA ; ZHANG LUYONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN109456274A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI ZHENG</creatorcontrib><creatorcontrib>LIU ROUJIA</creatorcontrib><creatorcontrib>ZHANG LUYONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI ZHENG</au><au>LIU ROUJIA</au><au>ZHANG LUYONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Benzimidazole derivative and preparation method and application as medicine thereof</title><date>2019-03-12</date><risdate>2019</risdate><abstract>The invention relates to a novel benzimidazole PPAR alpha/gamma/delta panto-agonist as shown in the general formula (I) and a preparation method thereof and application of a medicine compound containing the derivative in preparing a medicine for preventing or/and treating abnormal glucose metabolism or/and abnormal lipids metabolism disease. The PPAR alpha/gamma/delta panto-agonist has excellent in-vivo hypoglycemic activity and blood fat adjusting action, can be applied for preparing medicines for preventing or/and treating metabolic syndrome related diseases of diabetes, obesity, hyperlipidemia, atherosclerosis, fatty liver and the like, and has wide application prospects. 本发明涉及类通式(I)所示的新型苯并咪唑类PPARα/γ/δ泛激动剂、其制备方法及含有该衍生物的药物组合物作为制备预防或/和治疗葡萄糖代谢异常或/和脂质代谢异常疾病的药物用途。所述的PPARα/γ/δ泛激动剂具有优异的体内降血糖活性及调节血脂作用,可应用于制备预防或/和治疗糖尿病、肥胖症、高血脂、动脉粥样硬化及脂肪肝等代谢综合症相关疾病的药物,具有广阔的应用前景。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN109456274A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Benzimidazole derivative and preparation method and application as medicine thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A28%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI%20ZHENG&rft.date=2019-03-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN109456274A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true